Preventable Hazards from in Vitro Fertilization - A Case Series of CF Patients from Bulgaria.
carrier screening
cystic fibrosis
donor oocytes
preimplantation diagnosis
Journal
Balkan journal of medical genetics : BJMG
ISSN: 1311-0160
Titre abrégé: Balkan J Med Genet
Pays: Poland
ID NLM: 9806959
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
medline:
14
8
2023
pubmed:
14
8
2023
entrez:
14
8
2023
Statut:
epublish
Résumé
Pre-implantation genetic diagnosis (PGD) is not often performed when donor gametes are used, due to its high cost. This is with the presumption that the donors are healthy. We report on five cases of babies with confirmed cystic fibrosis (CF), being the result from in vitro fertilization (IVF) with donor (4 cases) or own gametes (one case). There has been no family history for CF in any of the families affected. The clinical presentation in the children ranged from meconium ileus to recurrent respiratory infections and severe nasal polyposis. The age of diagnosis also varied from birth until 9 years. Since one of the presented cases was discovered in a very renowned private IVF clinic, the clinic changed their own protocol, and currently they test every donor for CF carriership. The percentage of CF carriers in the donor population is roughly the same as the one predicted in the general population of Bulgaria - 1/33. Although PGD is costly, the costs for proper care for a CF patient are currently much higher. The more economical option would to screen every donor for CF carriership. IVF requires a lot of physical and psychological stamina. The couples that go through this procedure also require a great deal of hope. It is essential to be more preconscious for possible congenital diseases. We advocate every IVF center to test the donors for CF carriership or to provide PGD for their clients.
Identifiants
pubmed: 37576787
doi: 10.2478/bjmg-2023-0001
pii: bjmg-2023-0001
pmc: PMC10413990
doi:
Types de publication
Case Reports
Langues
eng
Pagination
83-88Informations de copyright
© 2023 N Yaneva et al., published by Sciendo.
Références
PLoS One. 2012;7(10):e47708
pubmed: 23082198
Balkan J Med Genet. 2020 Aug 26;23(1):57-62
pubmed: 32953410
Eur Respir J. 2014 Jan;43(1):20-3
pubmed: 24381320
J Paediatr Child Health. 2007 Nov;43(11):721-3
pubmed: 17924936
Int J Technol Assess Health Care. 1999 Winter;15(1):22-35
pubmed: 10407594
Lancet. 2009 May 30;373(9678):1891-904
pubmed: 19403164
Lancet Respir Med. 2016 Aug;4(8):662-674
pubmed: 27053340
Balkan J Med Genet. 2022 Jun 05;24(2):25-31
pubmed: 36249513
Reprod Biomed Online. 2010 Aug;21(2):186-95
pubmed: 20594975
J Cyst Fibros. 2010 Jan;9(1):29-35
pubmed: 19897426
N Engl J Med. 1992 Sep 24;327(13):905-9
pubmed: 1381054
Semin Respir Crit Care Med. 2009 Oct;30(5):569-78
pubmed: 19760544
Balkan J Med Genet. 2021 Jul 27;24(1):41-46
pubmed: 34447658
Mol Genet Genomic Med. 2019 Aug;7(8):e696
pubmed: 31245908
Aust N Z J Obstet Gynaecol. 2011 Dec;51(6):536-9
pubmed: 21875427
J Paediatr Child Health. 2008 Apr;44(4):232-3; author reply 233
pubmed: 18377372
J Clin Med. 2020 Aug 21;9(9):
pubmed: 32825766